These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9531518)

  • 1. Quantitative prediction of the interaction of midazolam and histamine H2 receptor antagonists in rats.
    Takedomi S; Matsuo H; Yamano K; Yamamoto K; Iga T; Sawada Y
    Drug Metab Dispos; 1998 Apr; 26(4):318-23. PubMed ID: 9531518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative prediction of metabolic inhibition of midazolam by itraconazole and ketoconazole in rats: implication of concentrative uptake of inhibitors into liver.
    Yamano K; Yamamoto K; Kotaki H; Sawada Y; Iga T
    Drug Metab Dispos; 1999 Mar; 27(3):395-402. PubMed ID: 10064572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of midazolam-CYP3A inhibitors interaction in the human liver from in vivo/in vitro absorption, distribution, and metabolism data.
    Yamano K; Yamamoto K; Katashima M; Kotaki H; Takedomi S; Matsuo H; Ohtani H; Sawada Y; Iga T
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):443-52. PubMed ID: 11259329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative prediction of metabolic inhibition of midazolam by erythromycin, diltiazem, and verapamil in rats: implication of concentrative uptake of inhibitors into liver.
    Yamano K; Yamamoto K; Kotaki H; Takedomi S; Matsuo H; Sawada Y; Iga T
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1118-26. PubMed ID: 10688631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrier-mediated active transport of histamine H2 receptor antagonists, cimetidine and nizatidine, into isolated rat hepatocytes: contribution of type I system.
    Nakamura H; Sano H; Yamazaki M; Sugiyama Y
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1220-7. PubMed ID: 7912279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of short-term and long-term pretreatment of Schisandra lignans on regulating hepatic and intestinal CYP3A in rats.
    Lai L; Hao H; Wang Q; Zheng C; Zhou F; Liu Y; Wang Y; Yu G; Kang A; Peng Y; Wang G; Chen X
    Drug Metab Dispos; 2009 Dec; 37(12):2399-407. PubMed ID: 19741040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of docosahexaenoic acid (DHA) on the intestinal metabolism of midazolam: in vitro and in vivo studies in rats.
    Hirunpanich V; Murakoso K; Sato H
    Int J Pharm; 2008 Mar; 351(1-2):133-43. PubMed ID: 18082981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of rat pulmonary metabolism to the elimination of lidocaine, midazolam, and nifedipine.
    Aoki M; Okudaira K; Haga M; Nishigaki R; Hayashi M
    Drug Metab Dispos; 2010 Jul; 38(7):1183-8. PubMed ID: 20371639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of H2-receptor antagonists on steady-state extraction of indocyanine green and lidocaine by the perfused rat liver.
    Roberts RK; Heath CA; Johnson RF; Speeg KV; Schenker S
    J Lab Clin Med; 1986 Feb; 107(2):112-7. PubMed ID: 2868064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stochastic prediction of CYP3A-mediated inhibition of midazolam clearance by ketoconazole.
    Chien JY; Lucksiri A; Ernest CS; Gorski JC; Wrighton SA; Hall SD
    Drug Metab Dispos; 2006 Jul; 34(7):1208-19. PubMed ID: 16611859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of the in vivo interaction between midazolam and macrolides based on in vitro studies using human liver microsomes.
    Ito K; Ogihara K; Kanamitsu S; Itoh T
    Drug Metab Dispos; 2003 Jul; 31(7):945-54. PubMed ID: 12814973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited sampling strategy in rats to predict the inhibited activities of hepatic CYP3A.
    Zhu XH; Jiao JJ; Zhang CL; Lou JS; Liu CX
    Lab Anim; 2009 Jul; 43(3):284-90. PubMed ID: 19237454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral ketoconazole on intestinal first-pass effect of midazolam and fexofenadine in cynomolgus monkeys.
    Ogasawara A; Kume T; Kazama E
    Drug Metab Dispos; 2007 Mar; 35(3):410-8. PubMed ID: 17142564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separate evaluation of intestinal and hepatic metabolism of three benzodiazepines in rats with cannulated portal and jugular veins: comparison with the profile in non-cannulated mice.
    Kuze J; Mutoh T; Takenaka T; Morisaki K; Nakura H; Hanioka N; Narimatsu S
    Xenobiotica; 2009 Nov; 39(11):871-80. PubMed ID: 19845438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
    Kharasch ED; Walker A; Hoffer C; Sheffels P
    Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cimetidine on hepatic cytochrome P450: evidence for formation of a metabolite-intermediate complex.
    Levine M; Bellward GD
    Drug Metab Dispos; 1995 Dec; 23(12):1407-11. PubMed ID: 8689952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism: the effect of assay conditions and regioselective stimulation by alpha-naphthoflavone, terfenadine and testosterone.
    Mäenpää J; Hall SD; Ring BJ; Strom SC; Wrighton SA
    Pharmacogenetics; 1998 Apr; 8(2):137-55. PubMed ID: 10022752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of ketoconazole, cimetidine and erythromycin on hepatic CYP3A activities in cats.
    Shah SS; Sasaki K; Hayashi Y; Motoyama S; Helmi AR; Khalil WF; Shimoda M
    J Vet Med Sci; 2009 Sep; 71(9):1151-9. PubMed ID: 19801894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of biliary excretion of methotrexate by probenecid in rats: quantitative prediction of interaction from in vitro data.
    Ueda K; Kato Y; Komatsu K; Sugiyama Y
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1036-43. PubMed ID: 11356926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrier-mediated uptake of H2-receptor antagonists by the rat choroid plexus: involvement of rat organic anion transporter 3.
    Nagata Y; Kusuhara H; Hirono S; Endou H; Sugiyama Y
    Drug Metab Dispos; 2004 Sep; 32(9):1040-7. PubMed ID: 15319347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.